Kuwait Recommendations on Vaccine Use in People with Inflammatory Rheumatic Diseases
Autor: | Aqeel Ghanem, Ahmad Alfadhli, Khaled Alsaeid, Yaser Ali, Ahmad Alenizi, Ahmad Dehrab, Hebah Alhajeri, Sawsan Hayat, Adeeba Al-Herz, Ali Aldei, Khuloud Mohammed, Entesar H. Husain, Waleed Al-Kandari, Adel Al-Awadhi, Eiman Hasan, F. Abutiban |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2018 |
Předmět: |
030203 arthritis & rheumatology
medicine.medical_specialty lcsh:Diseases of the musculoskeletal system business.industry Immunology Patient subgroups MEDLINE Review Article Vaccination 03 medical and health sciences 0302 clinical medicine Increased risk Rheumatology Family medicine Medicine 030212 general & internal medicine lcsh:RC925-935 business Antirheumatic drugs |
Zdroj: | International Journal of Rheumatology International Journal of Rheumatology, Vol 2018 (2018) |
ISSN: | 1687-9279 1687-9260 |
Popis: | People with IRD are at increased risk of infection, and in 2011 EULAR made general recommendations for vaccination in these patients. Global and European perspectives are important, but they cannot accurately reflect the individual situations of patients in different countries and regions. Based on our clinical experience and opinions, we have sought to tailor the original EULAR recommendations to include advice for vaccination with new agents approved in the intervening years—including the new class of targeted synthetic disease-modifying antirheumatic drugs. We have also considered the specific demographic needs of patients in local populations in the Gulf region. The resulting 16 recommendations are grouped into four main categories covering general vaccination guidelines and best-practice for all patients with IRD, followed by a set of recommended vaccines against specific pathogens. The last two categories include recommendations for certain patient subgroups with defined risks and for patients who wish to travel. |
Databáze: | OpenAIRE |
Externí odkaz: |